Adenovirus viremia and infection after reduced-intensity allogeneic hematopoietic stem cell transplant: should we institute a routine screening program?
Gabriela
G
Soriano
Miguel-Angel
MA
Perales
D000256:Adenoviridae / Q000302:isolation & purification*; D000257:Adenoviridae Infections / Q000209:etiology*; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D008297:Male; D014766:Viremia / Q000209:etiology*
D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab